Invention Grant
- Patent Title: Compositions and methods for modulating farnesoid X receptors
-
Application No.: US16056881Application Date: 2018-08-07
-
Publication No.: US10683271B2Publication Date: 2020-06-16
- Inventor: Donatella Chianelli , Xiaodong Liu , Valentina Molteni , John Nelson , Jason Thomas Roland , Paul Vincent Rucker , David Charles Tully
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Genomics Institute of the Novartis Research Foundation
- Agent Emily T. Wu
- Main IPC: C07D231/54
- IPC: C07D231/54 ; A61K31/4745 ; A61K31/4439 ; A61K31/4162 ; C07D471/04 ; C07D471/06 ; C07D491/052 ; A61K31/416
Abstract:
The present invention relates to compounds of Formula I, a stereoisomer, enantiomer, a pharmaceutically acceptable salt or an amino acid conjugate thereof; wherein variables are as defined herein; and their pharmaceutical compositions, which are useful as modulators of the activity of Farnesoid X receptors (FXR).
Public/Granted literature
- US20190062283A1 COMPOSITIONS AND METHODS FOR MODULATING FARNESOID X RECEPTORS Public/Granted day:2019-02-28
Information query
